Apr 02, 2026 | Trump's 100% Drug Tariff Splits Pharma; Lilly Foundayo Approved episode artwork

EPISODE · Apr 3, 2026 · 10 MIN

Apr 02, 2026 | Trump's 100% Drug Tariff Splits Pharma; Lilly Foundayo Approved

from The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus · host BZ Group

Trump signs 100% tariff on imported branded drugs—exemptions create pharma haves and have-nots. Lilly's oral obesity pill Foundayo wins FDA approval as analysts project blockbuster launch. Lilly-Centessa ($6.3B) andBiogen-Apellis ($5.6B) deals cap a $25.5B acquisition spree.visit us at: www.thepharmacloseout.com pharma, pharmaceutical, FDA, clinical trials, biotech, drugapprovals, healthcare, pharma podcast, The Pharma Closeout, Trump pharma tariff, pharmaceutical tariffs, Eli Lilly, Foundayo, orforglipron, FDA approval, obesity drugs, GLP-1, Novo Nordisk, Centessa, Biogen, Apellis, CVR,AstraZeneca, EMERALD-3, liver cancer, Vertex, cystic fibrosis, Alyftrek, Trikafta, EYLEA HD, Regeneron, aflibercept, Lipocine, postpartum depression,Merck, Infinimmune, Blackstone, Ambrosia, M&A, drug pricing, Lilly, AbbVie, GSK, Amgen

Trump signs 100% tariff on imported branded drugs—exemptions create pharma haves and have-nots. Lilly's oral obesity pill Foundayo wins FDA approval as analysts project blockbuster launch. Lilly-Centessa ($6.3B) andBiogen-Apellis ($5.6B) deals cap a $25.5B acquisition spree.visit us at: www.thepharmacloseout.com pharma, pharmaceutical, FDA, clinical trials, biotech, drugapprovals, healthcare, pharma podcast, The Pharma Closeout, Trump pharma tariff, pharmaceutical tariffs, Eli Lilly, Foundayo, orforglipron, FDA approval, obesity drugs, GLP-1, Novo Nordisk, Centessa, Biogen, Apellis, CVR,AstraZeneca, EMERALD-3, liver cancer, Vertex, cystic fibrosis, Alyftrek, Trikafta, EYLEA HD, Regeneron, aflibercept, Lipocine, postpartum depression,Merck, Infinimmune, Blackstone, Ambrosia, M&A, drug pricing, Lilly, AbbVie, GSK, Amgen

NOW PLAYING

Apr 02, 2026 | Trump's 100% Drug Tariff Splits Pharma; Lilly Foundayo Approved

0:00 10:16

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus?

This episode is 10 minutes long.

When was this The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus episode published?

This episode was published on April 3, 2026.

What is this episode about?

Trump signs 100% tariff on imported branded drugs—exemptions create pharma haves and have-nots. Lilly's oral obesity pill Foundayo wins FDA approval as analysts project blockbuster launch. Lilly-Centessa ($6.3B) andBiogen-Apellis ($5.6B) deals cap a...

Can I download this The Pharma Closeout | Daily Pharmaceutical & Biotech News in 15 minus episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!